1. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8 
Takaaki Konuma, Yasushi Miyazaki, Naoyuki Uchida, Kazuteru Ohashi, Tadakazu Kondo, Hirohisa Nakamae, Satoshi Takahashi, Takehiko Mori, Yukiyasu Ozawa, Chiaki Kato, Koji Iwato, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Ken Ishiyama 
Biology of Blood and Marrow Transplantation 
Volume 23, Issue 1, Pages (January 2017)
DOI: /j.bbmt
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
The probabilities of OS after HSCT for MDS patients harboring +8 according to age (A), FAB/WHO classification at HSCT (B), cytogenetics (C), previous treatment (D), donor source (E), and conditioning regimen (F).
Biology of Blood and Marrow Transplantation  , 75-80DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions